Post Parker Institute to Share Pancreatic Cancer Trial Results, Microbiome and Immunotherapy Research, and New CAR-T Approaches at AACR 2019
Post Parker Institute for Cancer Immunotherapy (PICI) Welcomes Weill Cornell Medicine to Cancer Research Consortium
Post James Allison, Parker Institute for Cancer Immunotherapy Director, Wins 2018 Nobel Prize in Medicine or Physiology for Research on Immune Checkpoint Inhibitors
Post Parker Institute for Cancer Immunotherapy, JDRF and the Helmsley Charitable Trust Form Cancer and Diabetes Research Initiative
Post Parker Institute for Cancer Immunotherapy Scientists to Present Research at ASCO 2017 on IDO Pathway Inhibitors, Novel CAR-Ts and the Microbiome’s Potential in Immunotherapy
Post The Parker Institute for Cancer Immunotherapy Awards $2.75 Million to Support Six Early Career Researchers from Leading Research Institutions
Post Parker Institute for Cancer Immunotherapy Aims to Speed Up Cancer Research Trials by Adopting Streamlined Review Process
Post Ute Dugan Joins the Parker Institute for Cancer Immunotherapy as Senior Vice President of Clinical Research